Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey

Dementia and Geriatric Cognitive Disorders

Volumn 26, Issue 1, 2008, Pages 15-25

  Garcia Santos J M ^a   Gavrila, D ^b   Antunez C ^c   Tormo, M J ^b   Salmeron D ^b   Carles, R ^c   Jimenez Veiga J ^c   Parrilla, G ^c   Torres Del Rio S ^a   Fortuna, L ^c   Navarro, C ^b  

^a HOSPITAL MORALES MESEGUER   (Spain)

^b DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Alzheimer's disease; Magnetic resonance imaging; Magnetic resonance spectroscopy; Mild cognitive impairment

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COMMUNITY SAMPLE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STANDARD;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASPARTIC ACID; BRAIN; CHOLINE; COGNITION DISORDERS; CREATINE; DATA COLLECTION; DEMENTIA; FEMALE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREDICTIVE VALUE OF TESTS; PROTONS; RESIDENCE CHARACTERISTICS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 47949105879     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000140624     Document Type: Article

References (39)

1. Holsinger T, Deveau J, Boustani M, Williams JW: Does this patient have dementia? JAMA 2007;297:2391-2404.
2. Nussbaum RL, Ellis CE: Alzheimer's disease and Parkinson's disease. N Engl J Med 2003;348:1356-1364.
3. Beard CM, Kokmen E, O'Brien PC, Kurland LT: The prevalence of dementia is changing over time in Rochester, Minnesota. Neurology 1995;45:75-79.
4. Tyas SL, Salazar JC, Snowdon DA, Desrosiers MF, Riley KP, Mendiondo MS, Kryscio RJ: Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol 2007;165:1231-1238.
5. Kantarci K, Jack CR Jr: Neuroimaging in Alzheimer's disease: an evidence-based review. Neuroimag Clin North Am 2003;13:197-209.
6. Celsis P: Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? Ann Med 2000;32:6-14.
7. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L: Introduction: mild cognitive impairment: beyond controversies, towards a consensus. J Intern Med 2004;256:181-182.
8. Modrego PJ: Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Curr Alzheimer Res 2006;3:161-170.
9. Valenzuela MJ, Sachdev P: Magnetic resonance spectroscopy in AD. Neurology 2001;56:592-598.
10. 1H MRS study. Neurology 2000;55:210-217.
11. 1H MRS study. Neurology 2001;57:626-632.
12. Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP: Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2005;384:23-28.
13. 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res 2004;1003:26-35.
14. Massoud F, Devi G, Stern Y, Lawton A, Goldman JE, Liu Y, Chin SS, Mayeux R: A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol 1999;56:1368-1373.
15. Lobo A, Ezquerra J, Gómez FB, Sala JM, Seva A: El minimental cognoscitivo: un test sencillo y práctico para detectar alteraciones intelectuales en pacientes médicos. Actas Luso Esp Neurol Psiq Cienc Af 1979;3:189-202.
16. Blesa R, Pujol M, Aguilar M, Santacruz P, Bertran-Serra I, Hernandez G, Sol JM, Pena-Casanova J, NORMACODEM Group: Normalisation of Cognitive and Functional Instruments for Dementia: Clinical validity of the 'mini-mental state' for Spanish speaking communities. Neuropsychologia 2001;39:1150-1157.
17. Winblad B, Palmer K, Jelik V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntii T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.
18. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1994;34:939-944.
20. Roman GC, Tatemichi TK, Erkinjuntii T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDSAIREN International Workshop. Neurology 1993;43:250-260.
21. Reisberg B, Ferris SH, de León MJ, Crook T: The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
22. Dixon RM, Bradley KM, Budge MM, Styles P, Smith D: Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 2002;125:2332-2341.
23. Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, Smith GE, Ivnik RJ, Tangalos EG, Jack CR Jr: Proton MR spectroscopy in mild cognitive impairment and Alzheimer's disease: comparison of 1.5 and 3T. Am J Neuroradiol 2003;24:843-849.
24. Martínez-Bisbal MC, Arana E, Martí-Bonmatí L, Martínez-Granados B, Celda B: Deterioro cognitivo: clasificación mediante espectroscopia de resonancia magnética de protón y contribución de la imagen convencional. Radiologia 2006;48:301-307.
25. Martínez-Bisbal MC, Arana E, Martí-Bonmatí L, Mollá E, Celda B: Cognitive impairment: classification by 1 H magnetic resonance spectroscopy. Eur J Neurol 2004;11:187-193.
26. Kantarci K, Xu YC, Shiung MM, O'Brien PC, Cha RH, Smith GE, Ivnik RJ, Boeve BF, Edland SD, Kokmen E, Tangalos EG, Petersen RC, Jack CR Jr: Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 2002;14:198-207.
27. Jessen F, Traeber F, Freymann N, Maier W, Schild HH, Heun R, Block W: A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease. Dement Geriatr Cogn Disord 2005;20:178-183.
28. Chao LL, Schuff N, Kramer JH, Du AT, Capizzano AA, O'Neill J, Wolkowitz OM, Jagust WJ, Chui HC, Miller BL, Yaffe K, Weiner MW: Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology 2005;64:282-289.
29. 1H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport 2001;12:2315-2317.
30. Maestú F, García-Segura J, Ortiz T, Montoya J, Fernández A, Gil-Gregorio P, Campo P, Fernández S, Viaño J, Portera A: Evidence of biochemical and biomagnetic interactions in Alzheimer's disease: a MEG and MR spectroscopy study. Dement Geriatr Cogn Disord 2005;20:145-152.
31. Godbolt AK, Waldman AD, MacManus DG, Schott JM, Frost C, Cipolotti L, Fox NC, Rossor MN: MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology 2006;66:718-722.
32. 1H-MRS in vivo. Magn Reson Med 1999;41:193-197.
33. Ganguli M, Dodge HH, Shen C, DeKosky ST: Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004;63:115-121.
34. Metastasio A, Rinaldi P, Tarducci R, Mariani E, Feliziani FT, Cherubini A, Pelliccioli GP, Gobbi G, Senin U, Mecocci P: Conversion of MCI to dementia: role of proton magnetic resonance spectroscopy. Neurobiol Aging 2006;27:926-932.
35. 1H MRS study. Am J Psychiatry 1999;156:1879-1886.
36. Ferguson KJ, MacLullich AMJ, Marshall I, Deary IJ, Starr JM, Seckl JR, Wardlaw JM: Magnetic resonance spectroscopy and cognitive function in healthy elderly men. Brain 2002;125:2743-2749.
37. Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Kramer J, Jagust W, Miller B, Wolkowitz OM, Yaffe K, Weiner MW: Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 2002;58:928-935.
38. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.
39. Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Jagust WJ, Chui HC, Kramer JH, Reed BR, Miller BL, Yaffe K, Weiner MW: Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology 2003;61:358-364.